Abstract
The aim of this study is to explore the actual situation of prostate cancer in a cohort of healthy population in Saudi Arabia and to show the feasibility of screening for this disease using the internationally agreed criteria. This study was conducted in the city of Riyadh, in the outpatient clinics of four different health facilities. All men presented to the outpatient clinics during the period of study, from January 2008 to December 2008, were invited to participate in the study, in which they were subjected to PSA blood testing and digital rectal examination (DRE). When either test was abnormal, transrectal ultrasound and multiple prostatic biopsies were performed for confirmation of the results. A total of 2100 healthy males who met the inclusion criteria of the study were evaluated. The highest percentage of men with PSA⩾4 ng ml–1 was in the age group 61–70, 51–60 years (42.7 and 31.8%, respectively). The number of subjects with an elevated PSA only was 172 (8.1%). Those having both elevated PSA and an abnormal DRE were 51 (2.4%). The total number referred to biopsy was 223. Fifty two subjects had a positive diagnosis of prostatic adenocarcinoma, which compromised 2.5% of the cohort studied. The cancer in 27 (52%) persons was organ confined, whereas in 14 (26.9%), it was metastatic. The prevalence rate of prostate cancer detected by screening was higher than expected and the disease was advanced. Larger community-based larger studies are highly warranted specially among high-risk groups.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 4 print issues and online access
$259.00 per year
only $64.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
US Preventive Services Task Force updates Prostate Cancer Screening recommendations. 2008. http://www.acponline.org/pressroom/pcancer.htm. Accessed October 2009.
National Cancer Institute. Prostate cancer screening. http://www.cancer.gov/cancertopics/pdq/screening/prostate/Patient. Accessed October 2009.
AUA American new guidelines on prostate cancer screening. April 2009. http://www.psa-rising.com/mednews/component/content/article/38-screening/78-aua-new-guidelines-on-prca-screening.
Smith RA, Cokkinides V, Eyre HJ . American Cancer Society Guidelines for the Early Detection of Cancer 2003. CA Cancer J Clin 2003; 53: 27–43.
What does shared decision making mean for prostate screening. http://blogs.wsj.com/health/2009/09/28/what-does-shared-decision-making-mean-for-prostate-screening/. Accessed September 2009.
Ministry of Health. Saudi National Cancer Registry. Cancer Incidence Report, Saudi Arabia, 2004.
Vadarampil ST, Jacobsen PB, Kash K, Watson IS, Saloup R, Pow-Sang J . Factors predicting PSA testing among first degree relatives of prostate cancer patients. Cancer Epidemiol Biomarkers Prev 2004; 13: 753–758.
UK prostate cancer incidence statistics. www.info.cancerresearchuk.org/cancerstats/types/prostate/incidence/. Accessed 9/2009.
Evans HS, Moller H . Recent trends in in prostate cancer incidence and mortality in Southeast England. Eur Urol 2003; 43 (4): 337–341.
Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V et al. Screening and prostate cancer mortality in a randomized European study. NEJM 2009; 360: 1320–1328.
Andriole GL, Grubb RL, Crawford ED, Buys SS, Chia D, Fouad MN et al. Mortality results from a randomized prostate cancer screening trial. NEJM 2009; 360 (13): 1310–1313.
Presti Jr JC, Chang JJ, Bhargava V, Shinohara K . The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol 2000; 163: 163–167.
Philip J, Hanchanale V, Foster CS, Javle P . Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocols. BJU Int 2006; 98: 559–562.
Djavan B, Margretier M . Biopsy standards for detection of prostate cancer world. J Urol 2007; 25: 11–17.
Acknowledgements
The study was supported by a grant from King Abdulaziz city for science and technology (KACST) and Princess Al Johara Al Ibrahim center for Cancer Research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Rabah, D., Arafa, M. Prostate cancer screening in a Saudi population: an explanatory trial study. Prostate Cancer Prostatic Dis 13, 191–194 (2010). https://doi.org/10.1038/pcan.2009.60
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/pcan.2009.60
Keywords
This article is cited by
-
Prostate cancer in Asian men
Nature Reviews Urology (2014)
-
Induction of apoptosis in cancer cell lines by the Red Sea brine pool bacterial extracts
BMC Complementary and Alternative Medicine (2013)